191 related articles for article (PubMed ID: 23378760)
21. Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors.
Wang Y; Hao J; Li Y; Zhang Z; Sha X; Han L; Fang X
Biomaterials; 2012 Jun; 33(18):4741-51. PubMed ID: 22445254
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity.
Wei Z; Yuan S; Hao J; Fang X
Eur J Pharm Biopharm; 2013 Feb; 83(2):266-74. PubMed ID: 23089310
[TBL] [Abstract][Full Text] [Related]
23. pH-triggered surface charge-switchable polymer micelles for the co-delivery of paclitaxel/disulfiram and overcoming multidrug resistance in cancer.
Huo Q; Zhu J; Niu Y; Shi H; Gong Y; Li Y; Song H; Liu Y
Int J Nanomedicine; 2017; 12():8631-8647. PubMed ID: 29270012
[TBL] [Abstract][Full Text] [Related]
24. An injectable thermosensitive hydrogel self-supported by nanoparticles of PEGylated amino-modified PCL for enhanced local tumor chemotherapy.
Guo J; Feng Z; Liu X; Wang C; Huang P; Zhang J; Deng L; Wang W; Dong A
Soft Matter; 2020 Jun; 16(24):5750-5758. PubMed ID: 32529197
[TBL] [Abstract][Full Text] [Related]
25. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X
Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367
[TBL] [Abstract][Full Text] [Related]
26. Paclitaxel and Tacrolimus Coencapsulated Polymeric Micelles That Enhance the Therapeutic Effect of Drug-Resistant Ovarian Cancer.
Wang N; He T; Shen Y; Song L; Li L; Yang X; Li X; Pang M; Su W; Liu X; Wu Q; Gong C
ACS Appl Mater Interfaces; 2016 Feb; 8(7):4368-77. PubMed ID: 26809267
[TBL] [Abstract][Full Text] [Related]
27. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells.
Hu Y; Xie J; Tong YW; Wang CH
J Control Release; 2007 Mar; 118(1):7-17. PubMed ID: 17241684
[TBL] [Abstract][Full Text] [Related]
28. Increased accumulation and retention of micellar paclitaxel in drug-sensitive and P-glycoprotein-expressing cell lines following ultrasound exposure.
Wan CP; Jackson JK; Pirmoradi FN; Chiao M; Burt HM
Ultrasound Med Biol; 2012 May; 38(5):736-44. PubMed ID: 22425383
[TBL] [Abstract][Full Text] [Related]
29. Core-crosslinked pH-sensitive degradable micelles: A promising approach to resolve the extracellular stability versus intracellular drug release dilemma.
Wu Y; Chen W; Meng F; Wang Z; Cheng R; Deng C; Liu H; Zhong Z
J Control Release; 2012 Dec; 164(3):338-45. PubMed ID: 22800578
[TBL] [Abstract][Full Text] [Related]
30. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.
Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y
Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790
[TBL] [Abstract][Full Text] [Related]
31. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs.
Park EK; Lee SB; Lee YM
Biomaterials; 2005 Mar; 26(9):1053-61. PubMed ID: 15369694
[TBL] [Abstract][Full Text] [Related]
33. Methoxy poly(ethylene glycol)-block-poly(delta-valerolactone) copolymer micelles for formulation of hydrophobic drugs.
Lee H; Zeng F; Dunne M; Allen C
Biomacromolecules; 2005; 6(6):3119-28. PubMed ID: 16283736
[TBL] [Abstract][Full Text] [Related]
34. Self-assembly of biotinylated poly(ethylene glycol)-poly(curcumin) for paclitaxel delivery.
Hu L; Li M; Zhang Z; Shen Y; Guo S
Int J Pharm; 2018 Dec; 553(1-2):510-521. PubMed ID: 30308274
[TBL] [Abstract][Full Text] [Related]
35. Toxic characteristics of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) nanospheres; in vitro and in vivo studies in the normal mice.
Kim SY; Lee YM; Baik DJ; Kang JS
Biomaterials; 2003 Jan; 24(1):55-63. PubMed ID: 12417178
[TBL] [Abstract][Full Text] [Related]
36. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
[TBL] [Abstract][Full Text] [Related]
37. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
[TBL] [Abstract][Full Text] [Related]
38. Surface modification of MPEG-b-PCL-based nanoparticles via oxidative self-polymerization of dopamine for malignant melanoma therapy.
Xiong W; Peng L; Chen H; Li Q
Int J Nanomedicine; 2015; 10():2985-96. PubMed ID: 25945046
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle.
Han M; Diao YY; Jiang HL; Ying XY; Chen DW; Liang WQ; Gao JQ
Int J Pharm; 2011 Nov; 420(2):404-11. PubMed ID: 21945184
[TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor-conjugated poly(ethylene glycol)-block- poly(delta-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics.
Zeng F; Lee H; Allen C
Bioconjug Chem; 2006; 17(2):399-409. PubMed ID: 16536472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
